Literature DB >> 11561799

Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.

L Kaiser1, A Morabia, H Stalder, A Ricchetti, R Auckenthaler, F Terrier, B Hirschel, N Khaw, J S Lacroix, D Lew.   

Abstract

The aim of the present study was to assess the hypothesis that, when present in nasopharyngeal secretions, Streptococcus pneumoniae. Haemophilus influenzae, and Moraxella catarrhalis play a pathogenic role early in the course of an upper respiratory tract infection. Adults with a clinical diagnosis of acute sinusitis or common cold were enrolled. Participants were randomly assigned in a double-blind manner to receive azithromycin 500 mg daily or placebo for 3 days. The effect of treatment on symptom evolution in the predefined subset of patients with Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis in their nasopharyngeal secretions was assessed. Of 265 patients enrolled, 132 received placebo and 133 azithromycin. Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis was identified in nasopharyngeal secretions of 77 patients (29%). In this predefined subgroup of patients with Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis, resolution of symptoms by day 7 occurred in 73% of those treated with azithromycin compared with 47% of those who received placebo (P=0.007). The median time before resolution of symptoms was 5 days in the azithromycin group compared to 7 days in the placebo group. Respiratory complications requiring antibiotic treatment occurred in 19% of patients in the placebo group and in 3% of the azithromycin group (P=0.025). In the remaining 188 patients without Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis, resolution of symptoms by day 7 was similar in both groups (69% in the placebo group vs. 64% in the azithromycin group [P=0.75]). Antibiotic treatment is of clinical benefit for patients with acute sinusitis or common cold when Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis is present in nasopharyngeal secretions. This observation provides new insights into the pathogenic role of these bacteria in the early stage of the common cold.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561799     DOI: 10.1007/s100960100544

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  Antibiotic efficacy in patients with a moderate probability of acute rhinosinusitis: a systematic review.

Authors:  Jakob M Burgstaller; Johann Steurer; David Holzmann; Gabriel Geiges; Michael B Soyka
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-18       Impact factor: 2.503

2.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

Review 3.  Acute rhinosinusitis : a pharmacoeconomic review of antibacterial use.

Authors:  Jean-Blaise Wasserfallen; Françoise Livio; Giorgio Zanetti
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Predicting response to antimicrobial therapy in children with acute sinusitis.

Authors:  Nader Shaikh; Ellen R Wald; Jong H Jeong; Marcia Kurs-Lasky; A'delbert Bowen; Lynda L Flom; Alejandro Hoberman
Journal:  J Pediatr       Date:  2013-12-22       Impact factor: 4.406

5.  Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Authors:  Malene Plejdrup Hansen; Anna M Scott; Amanda McCullough; Sarah Thorning; Jeffrey K Aronson; Elaine M Beller; Paul P Glasziou; Tammy C Hoffmann; Justin Clark; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-18

Review 6.  Antibiotics for acute rhinosinusitis in adults.

Authors:  Marieke B Lemiengre; Mieke L van Driel; Dan Merenstein; Helena Liira; Marjukka Mäkelä; An Im De Sutter
Journal:  Cochrane Database Syst Rev       Date:  2018-09-10

7.  The TARGET cohort study protocol: a prospective primary care cohort study to derive and validate a clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses.

Authors:  Niamh M Redmond; Rachel Davies; Hannah Christensen; Peter S Blair; Andrew M Lovering; John P Leeming; Peter Muir; Barry Vipond; Hannah Thornton; Margaret Fletcher; Brendan Delaney; Paul Little; Matthew Thompson; Tim J Peters; Alastair D Hay
Journal:  BMC Health Serv Res       Date:  2013-08-17       Impact factor: 2.655

Review 8.  Treatment options for acute sinusitis in children.

Authors:  Despina G Contopoulos-Ioannidis; John P A Ioannidis
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

9.  Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis.

Authors:  Joseph Dohar; Rafael Cantón; Robert Cohen; David John Farrell; David Felmingham
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-08-02       Impact factor: 3.944

10.  Detection of viral and bacterial pathogens in acute respiratory infections.

Authors:  Chidi N Obasi; Bruce Barrett; Roger Brown; Rose Vrtis; Shari Barlow; Daniel Muller; James Gern
Journal:  J Infect       Date:  2013-11-07       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.